2Symmans WF,Volm MD,Shapiro RL,et al.Paclitaxel-induced apoptosis and mitotic arrest assessed by Serial fine-needle aspiration:implications for early predietion of breast cancer response to neoadjuvant treatment[J].Clin Cancer Res,2000,6(12):4610-4617. 被引量：1
3Estva FJ,Valero V,Pueztai L,et al.Chemotherapy of metastatio breast cancer what to expect in 2001 and beyond[J].Oncologist,2001,6(2):133～146. 被引量：1
1[1]Giannil. Future direction of pacltaxel-based therapy of breast can cer. Semin Oncol, 1997,24:Suppl 17:91-96 被引量：1
2[2]Marty M. Prospective with docetaxel in the treatment of patients w ith breast cancer. Eur J Cancer Parta,1997,33:Suppl 7:23-29 被引量：1
3[3]Dieras V, Fumolean P, Kalla S，et al. Docetaxel in combination wi th doxorubicin or Vinorelbine.Eur J Cancer, 1997，33:Suppl 7:20-22 被引量：1
4[4]P' Andrew GM. Docetaxel and paclitaxel in breast cancer therapy:Pr esent status and future prospects.Semin Oncol, 1997,24:Suppl 13:27-44 被引量：1
5[5]Von Minickuitz G,Don Costa S, Eieruann W, et al. Maximized reduct ion of primary breast tumor size using preoperative chemotherapy with doxorubici n and docetaxel.J Clin Oncol,1999,17/7 (1999-2005) 被引量：1
6[6]Schmid M, Sauonigg H. The value of neoadjuvant chemotherapy in man agement of breast cancer.Acta Chir Austriaca, 1997,29:68-72 被引量：1
7[7]Sessa C, Pagani O, Martinellin G, et al. Dose-finding study of pa litaxel and cyclophosphamide in women with advanced breast cancer. Semin Oncol, 1997,24:52-57 被引量：1
8[8]Garcia-Carboncro R. Patients selction in high dose chemotherapy tr ials. Relevance in high-rick breast cancer. J Clin Oncol, 1997,15:3178-3184[ ZK) 被引量：1
10[10]Sledge GW Jr, Hu P, Falkson G, et al. Comparsion of chemotherapy with hormonal therapy as first-line therapy for metastatic，hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol, 2000, 18(2):262-266 被引量：1
